Embracing Complex Associations in Common Traits: Critical Considerations for Precision Medicine

Trends in Genetics

Volumn 32, Issue 8, 2016, Pages 470-484

  Hall, Molly A ^a   Moore, Jason H ^a   Ritchie, Marylyn D ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b GEISINGER HEALTH SYSTEM   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE INTERACTION; GENE LOCUS; GENETIC RISK; GENOME ANALYSIS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; PERSONALIZED MEDICINE; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM;

GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECISION MEDICINE;

EID: 84991093581     PISSN: 01689525     EISSN: 13624555     Source Type: Journal    
DOI: 10.1016/j.tig.2016.06.001     Document Type: Review

References (113)

1. 1 Kerem, B., et al. Identification of the cystic fibrosis gene: genetic analysis. Science 245 (1989), 1073–1080.
2. 2 Riordan, J.R., et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245 (1989), 1066–1073.
3. 3 Rommens, J.M., et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245 (1989), 1059–1065.
4. 4 Klein, R.J., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005), 385–389.
5. 5 Lander, E.S., et al. Initial sequencing and analysis of the human genome. Nature 409 (2001), 860–921.
6. 6 The International HapMap Consortium, A haplotype map of the human genome. Nature 437 (2005), 1299–1320.
7. 7 Bush, W.S., Moore, J.H., Chapter 11. Genome-wide association studies. PLoS Comput. Biol., 8, 2012, e1002822.
8. 8 Reich, D.E., Lander, E.S., On the allelic spectrum of human disease. Trends Genet. 17 (2001), 502–510.
9. 9 Smith, D.J., Lusis, A.J., The allelic structure of common disease. Hum. Mol. Genet. 11 (2002), 2455–2461.
10. 10 Collins, F.S., et al. Variations on a theme: cataloging human DNA sequence variation. Science 278 (1997), 1580–1581.
11. 11 Wang, W.Y.S., et al. Genome-wide association studies: theoretical and practical concerns. Nat. Rev. Genet. 6 (2005), 109–118.
12. 12 Welter, D., et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 42 (2014), D1001–D1006.
13. 13 Hindorff, L.A., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. U.S.A. 106 (2009), 9362–9367.
14. 14 Manolio, T.A., et al. Finding the missing heritability of complex diseases. Nature 461 (2009), 747–753.
15. 15 Manolio, T.A., Bringing genome-wide association findings into clinical use. Nat. Rev. Genet. 14 (2013), 549–558.
16. 16 Florez, J.C., Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes?. Diabetologia 51 (2008), 1100–1110.
17. 17 Visscher, P.M., et al. Five years of GWAS discovery. Am. J. Hum. Genet. 90 (2012), 7–24.
18. 18 Postmus, I., et al. Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins. Nat. Commun., 5, 2014, 5068.
19. 19 Hirschhorn, J.N., Genomewide association studies–illuminating biologic pathways. N. Engl. J. Med. 360 (2009), 1699–1701.
20. 20 Maher, B., Personal genomes: the case of the missing heritability. Nature 456 (2008), 18–21.
21. 21 Moore, J.H., et al. Bioinformatics challenges for genome-wide association studies. Bioinforma. Oxf. Engl. 26 (2010), 445–455.
22. 22 Hindorff, L.A., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. 106 (2009), 9362–9367.
23. 23 Solovieff, N., et al. Pleiotropy in complex traits: challenges and strategies. Nat. Rev. Genet. 14 (2013), 483–495.
24. 24 Sivakumaran, S., et al. Abundant pleiotropy in human complex diseases and traits. Am. J. Hum. Genet. 89 (2011), 607–618.
25. 25 White, J.K., et al. Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes. Cell 154 (2013), 452–464.
26. 26 McGuigan, K., et al. The nature and extent of mutational pleiotropy in gene expression of male Drosophila serrata. Genetics 196 (2014), 911–921.
27. 27 Tassabehji, M., et al. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat. Genet. 8 (1994), 251–255.
28. 28 Liu, M., et al. Identification of a CRYAB mutation associated with autosomal dominant posterior polar cataract in a Chinese family. Invest. Ophthalmol. Vis. Sci. 47 (2006), 3461–3466.
29. 29 Inagaki, N., et al. αB-crystallin mutation in dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 342 (2006), 379–386.
30. 30 Wang, Z., et al. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT–CLPTM1L region on chromosome 5p15.33. Hum. Mol. Genet. 23 (2014), 6616–6633.
31. 31 Pendergrass, S.A., et al. Phenome-wide sssociation studies: embracing complexity for discovery. Hum. Hered. 79 (2015), 111–123.
32. 32 Pendergrass, S.A., et al. The Use of phenome-wide association studies (PheWAS) for exploration of novel genotype–phenotype relationships and pleiotropy discovery. Genet. Epidemiol. 35 (2011), 410–422.
33. 33 Hall, M.A., et al. Detection of pleiotropy through a phenome-wide association study (PheWAS) of epidemiologic data as part of the Environmental Architecture for Genes Linked to Environment (EAGLE) study. PLoS Genet., 10, 2014, e1004678.
34. 34 Denny, J.C., et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations. Bioinformatics 26 (2010), 1205–1210.
35. 35 Denny, J.C., et al. Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies. Am. J. Hum. Genet. 89 (2011), 529–542.
36. 36 Denny, J.C., et al. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat. Biotechnol. 31 (2013), 1102–1111.
37. 37 Hebbring, S.J., et al. A PheWAS approach in studying HLA-DRB1*1501. Genes Immun. 14 (2013), 187–191.
38. 38 Namjou, B., et al. Phenome-wide association study (PheWAS) in EMR-linked pediatric cohorts, genetically links PLCL1 to speech language development and IL5-IL13 to eosinophilic esophagitis. Front. Genet., 5, 2014, 401.
39. 39 Cronin, R.M., et al. Phenome-wide association studies demonstrating pleiotropy of genetic variants within FTO with and without adjustment for body mass index. Front. Genet. 5 (2014), 1–14.
40. 40 Moore, C.B., et al. Phenome-wide association study relating pretreatment laboratory parameters with human genetic variants in AIDS clinical trials group protocols. Open Forum Infect. Dis., 2, 2015, ofu113.
41. 41 Moore, C.B., et al. Low frequency variants, collapsed based on biological knowledge, uncover complexity of population stratification in 1000 genomes project data. PLoS Genet., 9, 2013, e1003959.
42. 42 Moore, C.B., et al. Using biobin to explore rare variant population stratification. Pac. Symp. Biocomput. Pac. Symp. Biocomput., 2013, 332–343.
43. 43 Wu, M.C., et al. Powerful SNP-set analysis for case–control genome-wide association studies. Am. J. Hum. Genet. 86 (2010), 929–942.
44. 44 Gamazon, E.R., et al. A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 47 (2015), 1091–1098.
45. 45 Mitchell, S.L., et al. Investigating the relationship between mitochondrial genetic variation and cardiovascular-related traits to develop a framework for mitochondrial phenome-wide association studies. BioData Min., 7, 2014, 6.
46. 46 Hamilton, C.M., et al. The PhenX Toolkit: get the most from your measures. Am. J. Epidemiol. 174 (2011), 253–260.
47. 47 Huang, J., et al. Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. Am. J. Psychiatry 167 (2010), 1254–1263.
48. 48 Patel, C.J., Ioannidis, J.P.A., Studying the elusive environment in large scale. J. Am. Med. Assoc. 311 (2014), 2173–2174.
49. 49 Rappaport, S.M., Smith, M.T., Environment and disease risks. Science 330 (2010), 460–461.
50. 50 Wild, C.P., Complementing the genome with an ‘exposome’: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol. Biomarkers Prev. 14 (2005), 1847–1850.
51. 51 Kelly, S.P., et al. Smoking and cataract: review of causal association. J. Cataract Refract. Surg. 31 (2005), 2395–2404.
52. 52 Taylor, H.R., et al. Effect of ultraviolet radiation on cataract formation. N. Engl. J. Med. 319 (1988), 1429–1433.
53. 53 Volk, H.E., et al. Residential proximity to freeways and autism in the CHARGE study. Environ. Health Perspect. 119 (2011), 873–877.
54. 54 Volk, H.E., et al. Traffic-related air pollution, particulate matter, and autism. JAMA Psychiatry 70 (2013), 71–77.
55. 55 Patel, C.J., et al. An environment-wide association study (EWAS) on type 2 diabetes mellitus. PloS One, 5, 2010, e10746.
56. 56 Lind, P.M., et al. An environmental wide association study (EWAS) approach to the metabolic syndrome. Environ. Int. 55 (2013), 1–8.
57. 57 Patel, C.J., et al. Systematic identification of interaction effects between genome- and environment-wide associations in type 2 diabetes mellitus. Hum. Genet. 132 (2013), 495–508.
58. 58 Patel, C.J., et al. Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the United States national health and nutrition examination survey. Int. J. Epidemiol. 42 (2013), 1795–1810.
59. 59 Patel, C.J., et al. Investigation of maternal environmental exposures in association with self-reported preterm birth. Reprod. Toxicol. Elmsford N 45 (2014), 1–7.
60. 60 Hall, M.A., et al. Environment-wide association study (EWAS) for type 2 diabetes in the Marshfield Personalized Medicine Research Project Biobank. Pac. Symp. Biocomput. Pac. Symp. Biocomput., 2014, 200–211.
61. 61 Tzoulaki, I., et al. A nutrient-wide association study on blood pressure. Circulation 126 (2012), 2456–2464.
62. 62 Davis, M.A., et al. A dietary-wide association study (DWAS) of environmental metal exposure in US children and adults. PloS ONE, 9, 2014, e104768.
63. 63 Caspi, A., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 (2003), 386–389.
64. 64 Vineis, P., et al. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol. Biomarkers Prev. 10 (2001), 1249–1252.
65. 65 Yu, M.C., et al. Arylamine exposures and bladder cancer risk. Mutat. Res. - Fundam. Mol. Mech. Mutagen. 506-507 (2002), 21–28.
66. 66 Yang, S-J., et al. Relationship between genetic polymorphisms of ALDH2 and ADH1B and esophageal cancer risk: a meta-analysis. World J. Gastroenterol. 16 (2010), 4210–4220.
67. 67 Martinez, E., Multi-protein complexes in eukaryotic gene transcription. Plant Mol. Biol. 50 (2002), 925–947.
68. 68 Gallie, D.R., Protein–protein interactions required during translation. Plant Mol. Biol. 50 (2002), 949–970.
69. 69 Bateson, W., Mendel's Principles of Heredity. 1909, Cambridge University Press.
70. 70 Moore, J.H., The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum. Hered. 56 (2003), 73–82.
71. 71 Templeton, A., Epistasis and Complex Traits. 2000, Oxford University Press.
72. 72 Mackay, T.F.C., Epistasis and quantitative traits: using model organisms to study gene-gene interactions. Nat. Rev. Genet. 15 (2014), 22–33.
73. 73 Wagner, A., Robustness against mutations in genetic networks of yeast. Nat. Genet. 24 (2000), 355–361.
74. 74 Boone, C., et al. Exploring genetic interactions and networks with yeast. Nat. Rev. Genet. 8 (2007), 437–449.
75. 75 Tong, A.H.Y., et al. Global mapping of the yeast genetic interaction network. Science 303 (2004), 808–813.
76. 76 Szappanos, B., et al. An integrated approach to characterize genetic interaction networks in yeast metabolism. Nat. Genet. 43 (2011), 656–662.
77. 77 Moore, J.H., A global view of epistasis. Nat. Genet. 37 (2005), 13–14.
78. 78 Baryshnikova, A., et al. Genetic interaction networks: toward an understanding of heritability. Annu. Rev. Genomics Hum. Genet. 14 (2013), 111–133.
79. 79 Lehner, B., et al. Systematic mapping of genetic interactions in Caenorhabditis elegans identifies common modifiers of diverse signaling pathways. Nat. Genet. 38 (2006), 896–903.
80. 80 Gaertner, B.E., et al. More than the sum of its parts: a complex epistatic network underlies natural variation in thermal preference behavior in Caenorhabditis elegans. Genetics 192 (2012), 1533–1542.
81. 81 Byrne, A.B., et al. A global analysis of genetic interactions in Caenorhabditis elegans. J. Biol., 6, 2007, 8.
82. 82 Horn, T., et al. Mapping of signaling networks through synthetic genetic interaction analysis by RNAi. Nat. Methods 8 (2011), 341–346.
83. 83 Huang, W., et al. Inaugural Article: epistasis dominates the genetic architecture of Drosophila quantitative traits. Proc. Natl. Acad. Sci. 109 (2012), 15553–15559.
84. 84 Lloyd, V., et al. Not just pretty eyes: Drosophila eye-colour mutations and lysosomal delivery. Trends Cell Biol. 8 (1998), 257–259.
85. 85 Cheng, Y., et al. Mapping genetic loci that interact with myostatin to affect growth traits. Heredity 107 (2011), 565–573.
86. 86 Hanlon, P., et al. Three-locus and four-locus QTL interactions influence mouse insulin-like growth factor-I. Physiol. Genomics 26 (2006), 46–54.
87. 87 Gale, G.D., et al. A genome-wide panel of congenic mice reveals widespread epistasis of behavior quantitative trait loci. Mol. Psychiatry 14 (2009), 631–645.
88. 88 Rowe, H.C., et al. Biochemical networks and epistasis shape the Arabidopsis thaliana metabolome. Plant Cell 20 (2008), 1199–1216.
89. 89 Kroymann, J., Mitchell-Olds, T., Epistasis and balanced polymorphism influencing complex trait variation. Nature 435 (2005), 95–98.
90. 90 Nelson, M.R., et al. A combinatorial partitioning method to identify multilocus genotypic partitions that predict quantitative trait variation. Genome Res. 11 (2001), 458–470.
91. 91 Ritchie, M.D., et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am. J. Hum. Genet. 69 (2001), 138–147.
92. 92 Hemani, G., et al. Detection and replication of epistasis influencing transcription in humans. Nature 508 (2014), 249–253.
93. 93 Sun, Y.V., Integration of biological networks and pathways with genetic association studies. Hum. Genet. 131 (2012), 1677–1686.
94. 94 Ritchie, M.D., Using biological knowledge to uncover the mystery in the search for epistasis in genome-wide association studies. Ann. Hum. Genet. 75 (2011), 172–182.
95. 95 Ma, L., et al. Biological knowledge-driven analysis of epistasis in human GWAS with application to lipid traits. Methods Mol. Biol. Clifton NJ 1253 (2015), 35–45.
96. 96 Ritchie, M.D., Finding the epistasis needles in the genome-wide haystack. Methods Mol. Biol. Clifton NJ 1253 (2015), 19–33.
97. 97 Sun, X., et al. Analysis pipeline for the epistasis search–statistical versus biological filtering. Front. Genet., 2014, 5.
98. 98 Thomas, D.C., et al. Use of pathway information in molecular epidemiology. Hum. Genomics 4 (2009), 21–42.
99. 99 Cowper-Sal lari, R., et al. Layers of epistasis: genome-wide regulatory networks and network approaches to genome-wide association studies. Wiley Interdiscip. Rev. Syst. Biol. Med. 3 (2010), 513–526.
100. 100 Hall, M.A., et al. Biology-driven gene–gene interaction analysis of age-related cataract in the eMERGE network. Genet. Epidemiol. 39 (2015), 376–384.
101. 101 Kim, D., et al. Knowledge-driven genomic interactions: an application in ovarian cancer. BioData Min., 7, 2014, 20.
102. 102 Wang, Z., et al. Incorporating prior knowledge into gene network study. Bioinforma. Oxf. Engl. 29 (2013), 2633–2640.
103. 103 Bush, W.S., et al. A knowledge-driven interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility. Genes Immun. 12 (2011), 335–340.
104. 104 Ritchie, M.D., Using prior knowledge and genome-wide association to identify pathways involved in multiple sclerosis. Genome Med., 1, 2009, 65.
105. 105 Grady, B.J., et al. Finding unique filter sets in PLATO: a precursor to efficient interaction analysis in GWAS data. Pac. Symp. Biocomput. Pac. Symp. Biocomput., 2010, 315–326.
106. 106 Pendergrass, S.A., et al. Next-generation analysis of cataracts: determining knowledge driven gene–gene interactions using biofilter, and gene–environment interactions using the Phenx Toolkit. Pac. Symp. Biocomput. Pac. Symp. Biocomput., 2015, 495–505.
107. 107 Turner, S.D., et al. Knowledge-driven multi-locus analysis reveals gene-gene interactions influencing HDL cholesterol level in two independent EMR-linked biobanks. PloS ONE, 6, 2011, e19586.
108. 108 Huang, W., Mackay, T.F.C., The genetic architecture of quantitative traits cannot be inferred from variance component analysis. bioRxiv, 2016, 10.1101/041434 Published online February 26, 2016.
109. 109 Tyler, A.L., et al. Shadows of complexity: what biological networks reveal about epistasis and pleiotropy. BioEssays News Rev. Mol. Cell. Dev. Biol. 31 (2009), 220–227.
110. 110 Goldstein, D.B., Common genetic variation and human traits. N. Engl. J. Med. 360 (2009), 1696–1698.
111. 111 Donnelly, P., Progress and challenges in genome-wide association studies in humans. Nature 456 (2008), 728–731.
112. 112 Roberts, J.E., Ultraviolet radiation as a risk factor for cataract and macular degeneration. Eye Contact Lens 37 (2011), 246–249.
113. 113 Jiao, S., et al. SBERIA: set-based gene–environment interaction test for rare and common variants in complex diseases. Genet. Epidemiol. 37 (2013), 452–464.